Global Pharmaceutical Analytical Testing Outsourcing Market Report to 2031 – Trend Forecast and Growth Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Analytical Testing Outsourcing Market 2021-2031 by Service Type, Product Type, End User, Organization Size, and Region: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.

The global pharmaceutical analytical testing outsourcing market will reach $16,527.5 million by 2031, growing by 8.4% annually over 2021-2031, driven by the increasing pipelines for drug candidates, rising demand for additional analytical details on drugs as well as process development by regulatory agencies, entry of new contract organizations, and the lack of in-house equipment along with the rising adoption of outsourcing activities.

The report is based on a comprehensive research of the entire global pharmaceutical analytical testing outsourcing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain.

The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Companies Mentioned

• Boston Analytical, Inc.
• Charles River Laboratories International, Inc.
• Eurofins Scientific SE
• Exova Group PLC
• Intertek Pharmaceutical Services
• Laboratory Testing Inc.
• Pace Analytical Services LLC
• Pharmaceutical Product Development, LLC
• SGS SA
• Steris PLC
• Tentamus
• Toxikon Inc.
• West Pharmaceutical Services Inc.
• WuXi AppTec, Inc.

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Five Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global pharmaceutical analytical testing outsourcing market in every aspect of the classification from perspectives of Service Type, Product Type, End User, Organization Size, and Region.

Based on Service Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Bioanalytical Testing
• Clinical Testing
• Non-clinical Testing
• Method Development and Validation
• Extractable & Leachable
• Impurity Method
• Technical Consulting
• Other Methods
• Stability Testing
• Drug Substances Testing
• Accelerated Stability Testing
• Photostability Testing
• Other Stability Testings
• Other Services

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Raw Materials & Additives
• Active Pharmaceutical Ingredients (APIs)
• Finished Products

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Pharmaceutical & Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Other End Users

By Organization Size, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• SMEs
• Large Enterprises

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE,Saudi Arabia, South Africa and Rest of MEA)

For more information about this report visit https://www.researchandmarkets.com/r/nnlnqr

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900